{"drugs":["Aminosalicylic Acid","Paser"],"mono":{"0":{"id":"25550-s-0","title":"Generic Names","mono":"Aminosalicylic Acid"},"1":{"id":"25550-s-1","title":"Dosing and Indications","sub":[{"id":"25550-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Crohn's disease, Remission maintenance:<\/b> 500 mg ORALLY 3 times daily<\/li><li><b>Tuberculosis:<\/b> 4 grams ORALLY 3 times daily<\/li><\/ul>"},{"id":"25550-s-1-5","title":"Pediatric Dosing","mono":"<b>Tuberculosis:<\/b> 150 mg\/kg\/day ORALLY (in divided doses 3 times daily) up to a maximum of 12 grams\/day"},{"id":"25550-s-1-6","title":"Dose Adjustments","mono":"<b>renal impairment:<\/b> not recommended in patients with severe renal failure"},{"id":"25550-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Tuberculosis<br\/><b>Non-FDA Labeled Indications<\/b><ul><li>Crohn's disease, Remission maintenance<\/li><li>Ulcerative colitis<\/li><\/ul>"}]},"3":{"id":"25550-s-3","title":"Contraindications\/Warnings","sub":[{"id":"25550-s-3-9","title":"Contraindications","mono":"<ul><li>hypersensitivity to aminosalicylic acid products<\/li><li>renal disease, end-stage<\/li><\/ul>"},{"id":"25550-s-3-10","title":"Precautions","mono":"<ul><li>hepatic insufficiency; may have poor tolerance for the medication<\/li><li>hepatotoxicity and jaundice have been reported; monitoring recommended<\/li><li>peptic ulcer disease<\/li><li>impaired renal function<\/li><li>congestive heart failure (sodium salt)<\/li><li>duration of therapy longer than 1 month; consider maintenance Vitamin B12 therapy<\/li><\/ul>"},{"id":"25550-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"25550-s-3-12","title":"Breast Feeding","mono":"<ul><li>AAP: Drugs that have been associated with significant effects on some nursing infants and should be given to nursing mothers with caution.<\/li><li>Micromedex: Infant risk has been demonstrated.<\/li><\/ul>"}]},"4":{"id":"25550-s-4","title":"Drug Interactions","sub":{"2":{"id":"25550-s-4-15","title":"Moderate","mono":"<ul><li>Digoxin (probable)<\/li><li>Isoniazid (probable)<\/li><\/ul>"}}},"5":{"id":"25550-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Abdominal pain, Diarrhea, Nausea, Vomiting<\/li><li><b>Immunologic:<\/b>Hypersensitivity reaction, Rash with fever (5%)<\/li><\/ul><b>Serious<\/b><ul><li><b>Hematologic:<\/b>Thrombocytopenia<\/li><li><b>Hepatic:<\/b>Hepatotoxicity (up to 21%)<\/li><\/ul>"},"6":{"id":"25550-s-6","title":"Drug Name Info","sub":{"0":{"id":"25550-s-6-17","title":"US Trade Names","mono":"Paser<br\/>"},"2":{"id":"25550-s-6-19","title":"Class","mono":"Antitubercular<br\/>"},"3":{"id":"25550-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"25550-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"25550-s-7","title":"Mechanism Of Action","mono":"Aminosalicylic acid is a bacteriostatic, anti-tuberculosis agent against Mycobacterium tuberculosis. It inhibits folic acid and cell wall synthesis that leads to reduced iron uptake of M. tuberculosis. It is commonly used in multi-drug resistant tuberculosis therapy which aids in inhibiting the onset of bacterial resistance to streptomycin and isoniazid.<br\/>"},"8":{"id":"25550-s-8","title":"Pharmacokinetics","sub":[{"id":"25550-s-8-23","title":"Absorption","mono":"<ul><li>Oral: time to peak concentration, 5 h (1.5 h to 24 h)<\/li><li>Effect of food: decreases time to peak to 2 h (45 min to 24 h)<\/li><\/ul>"},{"id":"25550-s-8-24","title":"Distribution","mono":"<ul><li>Protein binding: approximately 50% to 60%<\/li><li>Protein binding: (kwashiorkor), reduced by 50%<\/li><\/ul>"},{"id":"25550-s-8-25","title":"Metabolism","mono":"Acetylation <br\/>"},{"id":"25550-s-8-26","title":"Excretion","mono":"<ul><li>Renal (glomerular filtration): 80%, 50% or more as metabolites<\/li><li>Dialyzable: no<\/li><\/ul>"},{"id":"25550-s-8-27","title":"Elimination Half Life","mono":"<ul><li>26.4 min<\/li><li>Renal disease: 30.8 min<\/li><\/ul>"}]},"9":{"id":"25550-s-9","title":"Administration","mono":"<b>Oral<\/b><br\/><ul><li>do not use if packet is swollen or the granules have lost their tan color and have turned dark brown or purple<\/li><li>sprinkle granules on apple sauce or yogurt or suspend in tomato, orange juice, grapefruit, grape, cranberry, apple, or fruit-juice containing punches<\/li><li>store in refrigerator or freezer; may be stored at room temperature for a short time<\/li><\/ul>"},"10":{"id":"25550-s-10","title":"Monitoring","mono":"<ul><li>chest X-ray<\/li><li>sputum culture<\/li><li>symptomatic improvement<\/li><li>liver function tests and symptoms of rash or fever, during first three months of therapy<\/li><\/ul>"},"11":{"id":"25550-s-11","title":"How Supplied","mono":"<b>Paser<\/b><br\/>Oral Powder for Suspension, Extended Release: 4 GM\/Packet<br\/>"},"13":{"id":"25550-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause abdominal pain, diarrhea, nausea, vomiting, or thrombocytopenia.<\/li><li>Instruct patients to report rash with fever or signs\/symptoms of hepatotoxicity, especially during the first 3 months of therapy.<\/li><\/ul>"}}}